Sequential cyclophosphamide-prednisone and vincristine-bleomycin (CPOB). An effective, schedule-dependent treatment for advanced diffuse histiocytic lymphoma. [electronic resource]
Producer: 19831021Description: 1133-41 p. digitalISSN:- 0008-543X
- Antineoplastic Agents -- adverse effects
- Antineoplastic Combined Chemotherapy Protocols
- Bleomycin -- administration & dosage
- Clinical Trials as Topic
- Cyclophosphamide -- administration & dosage
- Drug Administration Schedule
- Drug Therapy, Combination
- Follow-Up Studies
- Humans
- Lymphoma, Large B-Cell, Diffuse -- drug therapy
- Prednisolone
- Prednisone -- administration & dosage
- Vincristine -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.